Effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with recurrent respiratory tract infections (RTI): a general practice-based randomized controlled trial.

Trial Profile

Effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with recurrent respiratory tract infections (RTI): a general practice-based randomized controlled trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2010

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Hepatitis B vaccine recombinant
  • Indications Influenza virus infections; Pneumococcal infections; Respiratory tract infections
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 12 Jan 2010 Actual end date changed from 30 Jun 2005 to Jun 2006 as reported by ClinicalTrials.gov.
    • 14 May 2009 Additional trial identifier 84713819 and NTR223, additional lead trial centre and investigator identified, actual end date (30 Jun 2005) added as reported by ISRCTN: Current Controlled Trials record.
    • 14 May 2009 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top